FDA approves Amgen’s Parsabiv drug to treat chronic kidney disease
The U.S. Food and Drug Administration approved Amgen’s Parsabiv drug to treat patients with chronic kidney disease, the company announced on Feb. 7. The Thousand Oaks-based biotech company’s Parsabiv is the first therapy approved for the treatment of secondary hyperparathyroidism for patients on hemodialysis in 12 years, Amgen said. “We are excited about today’s approval Read More →
Amgen funds STEM program for Girl Scouts
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen beats analyst estimates for fourth quarter revenue
Thousand Oaks-based biotech giant Amgen reported revenue of $6 billion in the fourth quarter of 2016, besting analyst estimates of $5.74 billion and increasing 8 percent from the fourth quarter of 2015. The world’s largest biotech drug maker posted total revenues of $23 billion on the year, up 6 percent from 2015. Revenue gains were Read More →
Agilent cancer treatment approved in Europe
Agilent Technologies, with offices in Carpinteria, announced a product designed to identify previously untreated non-small cell lung cancer patients with a tumor proportion score of 50 percent or more was approved for use in Europe in conjunction with Merck’s Keytruda therapy. Before using the product – called PD-L1 IHC 22C3 pharmDx and developed by Agilent Read More →
CompuVision, Sagewood announce consolidation
IT services company CompuVision announced a partnership with health care technology services company Sagewood Systems, both based in Santa Barbara, on Jan. 31. The move will consolidate the companies’ technology, management and communications offerings under the CompuVision brand, it said in a news release, including consulting, enterprise applications and a “hyperconverged infrastructure” system that combines Read More →
Amgen CEO meets with Trump, vows to add 1,600 jobs
Amgen CEO Robert Bradway met with President Donald Trump on Jan. 31 and vowed to add 1,600 jobs, Bloomberg News reported. Trump told biotech leaders at a White House meeting that drug prices needed to come down and he would find a way to streamline the regulatory process. He has discussed having the government negotiate Read More →
InTouch Health to celebrate opening of Goleta headquarters
Telehealth developer InTouch Health will celebrate the grand opening of its new corporate headquarters at 7402 Hollister Ave. in Goleta on Jan. 31. The new facility includes an advanced technology “innovation center” that showcases medical care delivery solutions via robotics and cloud-based networks. InTouch created the world’s first robotic telehealth system shortly after its founding Read More →
